CVS icon

CVS Health

65.83 USD
-0.54
0.81%
At close Feb 14, 4:00 PM EST
After hours
65.78
-0.05
0.08%
1 day
-0.81%
5 days
21.03%
1 month
27.65%
3 months
19.50%
6 months
17.57%
Year to date
48.87%
1 year
-13.85%
5 years
-7.76%
10 years
-36.43%
 

About: CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.

Employees: 300,000

0
Funds holding %
of 6,831 funds
0
Analysts bullish %
of 8 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

22% more call options, than puts

Call options by funds: $1.79B | Put options by funds: $1.47B

2% more capital invested

Capital invested by funds: $62.8B [Q2] → $63.8B (+$1.04B) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 27 [Q2] → 27 (+0) [Q3]

3.58% less ownership

Funds ownership: 84.54% [Q2] → 80.96% (-3.58%) [Q3]

4% less funds holding

Funds holding: 1,872 [Q2] → 1,800 (-72) [Q3]

23% less first-time investments, than exits

New positions opened: 155 | Existing positions closed: 202

52% less repeat investments, than reductions

Existing positions increased: 477 | Existing positions reduced: 994

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$64
3%
downside
Avg. target
$72
9%
upside
High target
$80
22%
upside

8 analyst ratings

positive
100%
neutral
0%
negative
0%
Wells Fargo
Stephen Baxter
23% 1-year accuracy
9 / 39 met price target
11%upside
$73
Overweight
Maintained
13 Feb 2025
Truist Securities
David Macdonald
55% 1-year accuracy
53 / 96 met price target
15%upside
$76
Buy
Maintained
13 Feb 2025
Barclays
Andrew Mok
29% 1-year accuracy
20 / 68 met price target
11%upside
$73
Overweight
Maintained
13 Feb 2025
Leerink Partners
Michael Cherny
67% 1-year accuracy
26 / 39 met price target
14%upside
$75
Outperform
Upgraded
13 Feb 2025
Evercore ISI Group
Elizabeth Anderson
49% 1-year accuracy
17 / 35 met price target
1%downside
$65
Outperform
Maintained
27 Jan 2025

Financial journalist opinion

Based on 60 articles about CVS published over the past 30 days

Neutral
The Motley Fool
2 days ago
Why CVS Stock Thrashed the Market on Thursday
For the second day in a row, CVS Health's (CVS 4.98%) stock price saw a satisfying jump on Thursday. It closed the day almost 5% higher, on the back of both lingering optimism and news of another in a series of analyst price target raises.
Why CVS Stock Thrashed the Market on Thursday
Positive
Benzinga
3 days ago
CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
On Wednesday, CVS Health Corp CVS reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion.
CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock
Positive
CNBC
3 days ago
CVS shares are up 45% this year — here's why it may be starting to turn its business around
CVS Health could be starting to turn itself around after a dismal 2024. Its shares are up more than 45% this year, outperforming pharmacy rival Walgreens and other insurers like UnitedHealth Group and Cigna.
CVS shares are up 45% this year — here's why it may be starting to turn its business around
Positive
Market Watch
3 days ago
CVS wins upgrade to buy as analyst sees more upside potential than its peers
A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits businesses.
CVS wins upgrade to buy as analyst sees more upside potential than its peers
Neutral
MarketBeat
3 days ago
CVS Health: Earnings Beat Ignites Stock Rally
Shares of CVS Health Corporation NYSE: CVS experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's stock price increase comes after a period of decline, causing investors to question whether this is a temporary upswing or a sign of a genuine turnaround.
CVS Health: Earnings Beat Ignites Stock Rally
Positive
Benzinga
3 days ago
These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings
CVS Health Corp CVS reported upbeat earnings for its fourth quarter on Wednesday.
These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings
Positive
Seeking Alpha
3 days ago
CVS Health Jumps On Q4 Earnings Beat, But Downgrading To Hold
Despite a >10% rise in CVS Health's stock price from my initial BUY recommendation, CVS Health is downgraded to Hold due to substantial political risks and declining cash flow. CVS faces significant challenges, including DOJ lawsuits, potential business separation, political scrutiny, and declining cash flow, impacting its turnaround prospects. CVS reported strong Q4 sales and new leadership from the new CEO David Joyner may bode well for shareholders.
CVS Health Jumps On Q4 Earnings Beat, But Downgrading To Hold
Positive
Investopedia
4 days ago
S&P 500 Gains and Losses Today: CVS Stock Jumps as Pharmacy Segment Delivers Growth
Major U.S. equities indexes were mixed on Wednesday as the latest Consumer Price Index (CPI) data showed an unexpected uptick in inflation during January.
S&P 500 Gains and Losses Today: CVS Stock Jumps as Pharmacy Segment Delivers Growth
Positive
PYMNTS
4 days ago
CVS Health's All-in-One App Aims to Personalize Healthcare
Digital personalization in the healthcare industry is critical to elevate the customer experience. In keeping with that theme, CVS Health CEO David Joyner identified advancing digital strategies as one of four priorities for 2025 during the company's fourth-quarter earnings call Wednesday (Feb. 12).
CVS Health's All-in-One App Aims to Personalize Healthcare
Positive
Benzinga
4 days ago
Nasdaq Edges Higher; CVS Health Shares Jump Following Upbeat Earnings
U.S. stocks traded mostly lower toward the end of trading, while the Nasdaq Composite edged higher on Wednesday.
Nasdaq Edges Higher; CVS Health Shares Jump Following Upbeat Earnings
Charts implemented using Lightweight Charts™